Heart failure with mid-range ejection fraction: 3 years after its creation, what do we know?
Who are the patients with mid-range ejection fraction? Why did the European Society of Cardiology create this category? Does this new group have differences in its epidemiology and in its response to pharmacological therapy? In this descriptive review we seek to characterize heart failure patients w...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/128882 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/128882 |